UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
Location status: Recruiting
NCT Number: NCT05978128
This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely accepted and is commonly used among eligible women. Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer. There are many reasons lung screening isn't being used when compared to breast screening, such as smoking stigma and fear, along with a lack of awareness of lung screening. By conducting this trial, researchers want to assess the effectiveness of advocates and supporters of breast and lung screening, and to learn about the psychological barriers to cancer screening, identifying those that are unique to lung screening.
Interested in participating?
Request Info40 year–80 year
All sexes
Interventional
Not applicable
Los Angeles, California, 90095, United States
Location status: Recruiting
PRIMARY OBJECTIVES:
I. Determine the number of patients undergoing breast screening who are eligible to participate in lung screening.
II. Determine whether patients currently participating in cancer screening (breast OR lung) are successful as "cancer screening advocates." III. Determine whether laypersons who are aware of screening (including those who accompany friends and family members to their screening appointments) are successful as "cancer screening advocates." IV. Identify knowledge base and psychological barriers to screening through surveys of potential screening participants.
OUTLINE:
Participants access an electronic patient portal with educational materials at baseline, 1- and 2-year follow-ups, and also interact with a patient navigator on study. Patients also receive materials to share with their friends/family on benefits of breast and lung cancer screening on study.
After completion of study intervention, participants are followed up yearly for up to 3 years.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Access electronic patient portal with educational material
Receive materials on breast/lung cancer screening
Interact with a patient navigator
Other names: Patient Navigator Program
Ancillary studies
Time frame: Up to 3 years
By following up with patients over the defined study period and assessing whether they obtained an incidence screen completed at one-year +/- 3 months from the recommended time. Will also measure the rates of survey completion by consented participants, the number of clicks and time spent reviewing educational materials, and the number of new participants who contacted the program through a referral by another participant.
Time frame: Up to 3 years
Considered successful if increased lung cancer screening referrals are a direct result of women receiving screening mammograms inviting and educating friends and family about lung cancer screening.
Jonsson Comprehensive Cancer Center
Other
Utilizing Spheres of Influence to Increase Cancer Screening: Empowering Community Health Advocates
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT06995898
Adenocarcinoma, Adnexal Diseases
Pleasanton, California, United States
View Trial DetailsNCT00991094
Breast Carcinoma, Breast Diseases
Houston, Texas, United States
View Trial DetailsNCT07291414
Breast Carcinoma, Breast Diseases
Ann Arbor, Michigan, United States
View Trial Details